Synthetic DNA Firm Twist Bio Raises $26M, Wins $5.1M DARPA Contract | GenomeWeb

NEW YORK (GenomeWeb News) – Synthetic DNA manufacturing firm Twist Bioscience today announced it has raised $26 million in a Series B financing round and received a $5.1 million federal grant to further develop the company's technology platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."